- Previous Close
14.34 - Open
13.94 - Bid 13.97 x --
- Ask 14.00 x --
- Day's Range
13.79 - 14.38 - 52 Week Range
10.00 - 17.50 - Volume
5,300,200 - Avg. Volume
6,426,597 - Market Cap (intraday)
2.706B - Beta (5Y Monthly) 1.40
- PE Ratio (TTM)
35.85 - EPS (TTM)
0.39 - Earnings Date --
- Forward Dividend & Yield 0.42 (2.93%)
- Ex-Dividend Date Nov 19, 2024
- 1y Target Est
--
HySum Flexibles Global, Inc. engages in the manufacture, sale, and export of pharmaceutical packaging products in China and internationally. It offers pharmaceuticals packaging products, including cold-form, tropical foil, PVC/Aclar sheets, PTP lidding, hipack child-resistant packaging, hipack AL/PE strip packs, hipack complex laminated flexible films, lamination foil and pouch, composite films, hipack AL/PE suppository laminates, PVC,PVDC/PVC pharmaceutical packaging, PE series bags, and PP, PE, and COP bottles; food packaging, comprising three-layer co-extruded PE films, top-blown and bottom-blown multi-layer co-extruded high barrier films, and multi-layer co-extruded sheets; new energy material packaging, such as aluminum plastic films; precision injection packaging comprising precision injection molded packaging, desiccant combination, precision dosing devices, diagnostic reagent package, plastic vaccine vials, and high-barrier vials. The company was formerly known as Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. and changed its name to HySum Flexibles Global, Inc. in January 2024. The company was founded in 2005 and is headquartered in Shanghai, China.
www.hysum.com896
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 300501.SZ
View MorePerformance Overview: 300501.SZ
Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300501.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300501.SZ
View MoreValuation Measures
Market Cap
2.71B
Enterprise Value
2.91B
Trailing P/E
35.85
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.34
Price/Book (mrq)
1.55
Enterprise Value/Revenue
2.55
Enterprise Value/EBITDA
16.15
Financial Highlights
Profitability and Income Statement
Profit Margin
8.20%
Return on Assets (ttm)
2.71%
Return on Equity (ttm)
5.02%
Revenue (ttm)
1.09B
Net Income Avi to Common (ttm)
89.34M
Diluted EPS (ttm)
0.39
Balance Sheet and Cash Flow
Total Cash (mrq)
540.88M
Total Debt/Equity (mrq)
34.88%
Levered Free Cash Flow (ttm)
-24.48M